Ubrogepant-[d5]

Ask the supplier | View on supplier's website

Labelled Ubrogepant. Ubrogepant is a selective oral calcitonin gene-related peptide (CGRP) receptor antagonist originated by Merck & Co. In Sep 2016, Allergan initiated a phase III extension trial for Migraine in USA.

Supplier	BOC Sciences
Product #	BLP-007550
Pricing	Inquire
Molecular Weight	554.57
Molecular Formula	C29H21D5F3N5O3

Feedback